Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 21 Neoplasm Metastasis 3 Sleep Initiation and Maintenance Disorders 1 Prostatic Diseases 1 Prostate Cancer Metastatic Disease 1 Neoadjuvant Therapy 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 High Risk Prostate Cancer 1 Hematologic Neoplasms 1 Genital Diseases, Male 1 Fatigue 1 Depression 1 Adenocarcinoma 1

Interventions

apalutamide 1 Receptors, Androgen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × High Risk Prostate Cancer × apalutamide × Clear all

NCT06758882 2025-01-06

STAPLE

A.O.U. Città della Salute e della Scienza

Phase 2 Recruiting

High Risk Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡